Skip to main content

Table 1 Comparisons of demographic, clinical characteristics and bacteria alpha diversity between BPH group and normal control group

From: The impact of urine microbiota in patients with lower urinary tract symptoms

 

BPH (n = 77)

Control (n = 30)

P value

Demographic

 Age

69.44 ± 8.23

61.97 ± 8.32

 < 0.001a

 Body mass index

24.17 ± 3.33

24.55 ± 2.87

0.616

Clinical Characteristics

 Fasting blood glucose

110.89 ± 17.05

114.48 ± 26.77

0.436

 Prostate specific antigen (PSA)

3.02 ± 3.21

2.37 ± 3.94

0.406

 Free PSA

0.60 ± 0.11

0.69 ± 1.25

0.613

 Hemoglobin A1c (%)

5.81 ± 0.67

5.88 ± 0.53

0.660

 Creatinine

0.98 ± 0.22

0.93 ± 0.18

0.393

 BUN

15.44 ± 4.94

13.22 ± 2.93

0.036

 HDL

53.93 ± 24.43

47.91 ± 11.76

0.239

 Cholesterol

181.51 ± 42.61

182.28 ± 28.15

0.933

 LDL

110.61 ± 33.82

116.75 ± 26.46

0.409

 Testosterone

551.68 ± 246.50

540.75 ± 158.96

0.836

 GOT

25.96 ± 7.63

26.50 ± 7.79

0.804

 GPT

26.133 ± 12.86

30.56 ± 20.82

0.210

 TG

108.68 ± 66.63

102.52 ± 44.11

0.667

 IPSS

6.25 ± 4.19

2.16 ± 1.37

 < 0.001a

 Quality of life scores

2.09 ± 0.68

1.2 ± 0.41

 < 0.001a

Parameter of Bacterial Alpha Diversity

 Observed species

256.17 ± 65.29

254.70 ± 51.58

0.912

 Chao1

284.40 ± 65.63

288.21 ± 63.05

0.786

 ACE index

277.65 ± 64.78

280.21 ± 57.85

0.850

 Shannon index

5.81 ± 1.04

5.59 ± 0.90

0.314

 Simpson index

0.93 ± 0.08

0.92 ± 0.06

0.697

  1. aIPSS: International Prostate Symptom Score